These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ER, estrogen receptor AND Clinical Outcome
14 results:

  • 1. estrogen concentration and estrogen receptor-β expression in postmenopausal colon cancer considering patient/tumor background.
    Honma N; Arai T; Matsuda Y; Fukunaga Y; Akishima-Fukasawa Y; Yamamoto N; Kawachi H; Ishikawa Y; Takeuchi K; Mikami T
    J Cancer Res Clin Oncol; 2022 May; 148(5):1063-1071. PubMed ID: 35032217
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
    Filipits M; Rudas M; Singer CF; Fitzal F; Bago-Horvath Z; Greil R; Balic M; Lax SF; Halper S; Hulla W; Wu NC; Liu X; Weidler J; Bates M; Hlauschek D; Gnant M; Dubsky P
    ESMO Open; 2021 Aug; 6(4):100228. PubMed ID: 34371382
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
    Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
    Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer.
    Carberry S; D'Orsi B; Monsefi N; Salvucci M; Bacon O; Fay J; Rehm M; McNamara D; Kay EW; Prehn JHM
    Cell Death Dis; 2018 Jan; 9(2):125. PubMed ID: 29374142
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes.
    Peng J; Ou Q; Wu X; Zhang R; Zhao Q; Jiang W; Lu Z; Wan D; Pan Z; Fang Y
    Chin J Cancer; 2017 Nov; 36(1):89. PubMed ID: 29122010
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer.
    Ryan D; Carberry S; Murphy ÁC; Lindner AU; Fay J; Hector S; McCawley N; Bacon O; Concannon CG; Kay EW; McNamara DA; Prehn JH
    J Transl Med; 2016 Jul; 14(1):196. PubMed ID: 27369741
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Association between colorectal cancer and estrogens].
    Honma N; Arai T; Muramatsu M
    Nihon Rinsho; 2014 Jan; 72(1):49-55. PubMed ID: 24597348
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Aromatase in colon carcinoma.
    Sato R; Suzuki T; Katayose Y; Miura K; Shiiba K; Miki Y; Kamogawa Y; Yamamoto K; Takayuki ; Egawa S; Unno M; Sasano H
    Anticancer Res; 2012 Aug; 32(8):3069-75. PubMed ID: 22843875
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor.
    Sase T; Suzuki T; Miura K; Shiiba K; Sato I; Nakamura Y; Takagi K; Onodera Y; Miki Y; Watanabe M; Ishida K; Ohnuma S; Sasaki H; Sato R; Karasawa H; Shibata C; Unno M; Sasaki I; Sasano H
    Int J Cancer; 2012 Nov; 131(10):2284-93. PubMed ID: 22396198
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin.
    Gordon MA; Zhang W; Yang D; Iqbal S; El-Khouiery A; Nagashima F; Lurje G; Labonte M; Wilson P; Sherrod A; Ladner RD; Lenz HJ
    Pharmacogenomics; 2011 Jan; 12(1):27-39. PubMed ID: 21174620
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer.
    Press OA; Zhang W; Gordon MA; Yang D; Haiman CA; Azuma M; Iqbal S; Lenz HJ
    Pharmacogenomics J; 2011 Oct; 11(5):375-82. PubMed ID: 20548329
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of 5 novel genes methylated in breast and other epithelial cancers.
    Hill VK; Hesson LB; Dansranjavin T; Dallol A; Bieche I; Vacher S; Tommasi S; Dobbins T; Gentle D; Euhus D; Lewis C; Dammann R; Ward RL; Minna J; Maher ER; Pfeifer GP; Latif F
    Mol Cancer; 2010 Mar; 9():51. PubMed ID: 20205715
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
    Jögi A; Brennan DJ; Rydén L; Magnusson K; Fernö M; Stål O; Borgquist S; Uhlen M; Landberg G; Påhlman S; Pontén F; Jirström K
    Mod Pathol; 2009 Dec; 22(12):1564-74. PubMed ID: 19734850
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. How different are luminal A and basal breast cancers?
    Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Buttarelli M; Jacquemier J; Chaffanet M; Maraninchi D; Viens P; Birnbaum D
    Int J Cancer; 2009 Mar; 124(6):1338-48. PubMed ID: 19058218
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.